Pharmaceutical

Broken String Biosciences teams up with Francis Crick Institute for ALS research

The companies will utilise Broken String’s DNA break mapping platform Induce-seq for ALS research.

May 9, 2024 - 00:00
Broken String Biosciences teams up with Francis Crick Institute for ALS research
The companies will utilise Broken String’s DNA break mapping platform Induce-seq for ALS research.
Read the original article

Tags:

Previous Article

TerSera’s ZOLADEX LA gains Health Canada approval for breast cancer

Next Article

Psilocybin effective in treating depression

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

KeyBioscience and Eli Lilly extend partnership for obesity treatments

KeyBioscience and Eli Lilly extend partnership for obes...

Oct 12, 2024

Novartis acquires Mariana in $1.75bn deal to strengthen radioligand portfolio 

Novartis acquires Mariana in $1.75bn deal to strengthen...

May 3, 2024

Singapore approves mpox vaccine as it adds border infection checks

Singapore approves mpox vaccine as it adds border infec...

Aug 29, 2024